
Dec 29 (Reuters) - Bubs Australia Ltd BUB.AX:
FDA CONTINUES REVIEW OF BUBS' INFANT FORMULA SUBMISSIONS
CONFIRMS THAT IT IS ON TRACK TO RECEIVE FDA APPROVAL
FDA CONFIRMED IT WILL CONTINUE TO FACILITATE IMPORTATION, OTHERS OF BUBS' INFANT FORMULA PRODUCTS IN US AFTER 31 DEC 2025